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ABSTRACT
Objectives: Timely diagnosis of colorectal cancer is
important to improve survival. This study explored
symptom appraisal and help-seeking among patients
referred to specialist services with symptoms of
colorectal cancer.
Design: Qualitative in-depth interview study.
Setting and participants: Participants were recruited
on referral to gastroenterology clinics (North East and
East of England); interviews were conducted soon after
referral. We purposively sampled participants to ensure
a range of accounts in terms of age, sex, diagnosis
and geographical location.
Methods: Data collection and analysis were
underpinned by the Model of Pathways to Treatment.
Framework analysis was used to explore the data
within and across cases, focusing on patient beliefs
and experiences, disease factors and healthcare
influences.
Results: 40 participants were interviewed (aged
43–87 years, 17 women, 18 diagnosed with colorectal
cancer). Patients diagnosed with and without colorectal
cancer had similar symptom pathways. We found a
range of interacting and often competing
biopsychosocial, contextual and cultural influences on
the way in which people recognised, interpreted and
acted on their symptoms. People attempted to
‘maintain normality’ through finding benign
explanations for their symptoms. Bodily changes were
appraised within the context of usual bowel patterns,
comorbidities and life events, and decisions to seek
help were made in relation to expectations about the
course of symptoms. The ‘private nature’ of colorectal
cancer symptoms could affect both their identification
and discussions with others including healthcare
professionals. Within the context of the National Health
Service, people needed to legitimise appropriate use of
healthcare services and avoid being thought of as
wasting doctors’ time.
Conclusions: Findings provide guidance for
awareness campaigns on reducing stigma around
appraising and discussing bowel movements, and the
importance of intermittent and non-specific symptoms.
Altering perceptions about the appropriate use of
health services could have a beneficial effect on time to
presentation.
INTRODUCTION
Colorectal cancer (CRC) is the second most
common cause of cancer-related death in
Europe.1 2 While the recent implementation
of population-based CRC screening pro-
grammes across many countries will help to
reduce CRC mortality,3 most CRCs are still
detected symptomatically,4 and prompt symp-
tomatic diagnosis remains a priority. The
relationship between time to diagnosis and
survival is complex;5 however, later stage at
diagnosis is thought to be one of the factors
responsible for the lower CRC survival rates
in the UK and Denmark in relation to other
comparable Western countries.6 The time
from symptom onset to healthcare-seeking
has been estimated to represent the greatest
proportion of the total time to diagnosis.7 In
order to develop interventions to optimise
early cancer diagnosis and improving treat-
ment outcomes, it is therefore essential to
Strengths and limitations of this study
▪ We believe this study is the first to compare the
appraisal and help-seeking experiences of
patients with symptoms of colorectal cancer
(such as rectal bleeding, a change in bowel habit
and abdominal pain) between people subse-
quently diagnosed with colorectal cancer and
people diagnosed with other non-cancer condi-
tions; we were unable to identify any differences.
▪ The study was guided by the Aarhus statement
recommendations on improving design and
reporting of studies on early cancer diagnosis.
▪ Risks of recall bias and post hoc rationalisation
were reduced by recruiting at the time of referral
to specialist care, and interviewing patients
before or close to diagnosis.
▪ The ‘private nature’ of colorectal symptoms is a
novel finding, and contributes to our understand-
ing of why some people may not present in a
timely way with symptoms suspicious of colo-
rectal cancer. Symptoms that can no longer be
kept private may prompt help-seeking.
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understand inﬂuences on symptom appraisal and
healthcare-seeking.
There remains limited understanding of why people
choose to seek care for symptoms associated with CRC
when they do, and how the inﬂuence of contributory
factors varies throughout the diagnostic pathway.8
Although there are generic inﬂuences on the way in
which people interpret and act on their symptoms, there
may also be inﬂuences speciﬁc to the site of the
cancer.9 10 The time taken to recognise the potentially
serious nature of symptoms is the most commonly
reported factor contributing to consultation behaviour
for symptoms of CRC and delayed diagnosis.11 However,
warning signs for CRC, such as persistent change in
bowel habit and rectal bleeding, are common,12 and are
not a sign of serious illness for most people who experi-
ence them.13–15
To date, research in this area has largely focused on
healthcare-seeking behaviour for a particular symptom
such as rectal bleeding, or has utilised retrospective
accounts of patients with CRC whose diagnosis may
colour their narrative.16 In contrast, this study aimed to
investigate symptom appraisal and help-seeking among
patients with a range of symptoms suggestive of CRC as
they were referred from primary care to secondary care
for further investigation.
METHODS
Participants and procedures
We conducted semistructured in-depth qualitative inter-
views with individual participants aged ≥40 years who
had been referred with symptoms suggestive of CRC to
ﬁve gastroenterology clinics at hospitals in the North
East and East of England. This study was nested within a
larger prospective study (the SYMPTOM study) that
aimed to identify factors associated with later presenta-
tion to primary care and later stage at diagnosis for
people with symptoms suspicious of lung, colorectal and
pancreatic cancer.17 18 Participants were purposively
sampled from the responders who had agreed to be
interviewed, to ensure diversity in terms of age, gender,
geographical location and diagnoses. The semistruc-
tured interview schedule focused on contributing
factors, intervals, events and processes within the
appraisal and help-seeking intervals of the Model of
Pathways to Treatment.19 20 Open-ended questions
allowed additional topics to be explored.
Interviews lasted between 40 and 90 min and were
undertaken by NH, LB and KM between 2011 and 2013.
They were scheduled as close to the referral to secondary
care as possible to minimise recall bias (median period
from referral to interview 10 weeks, range 4 weeks to 5
months), and written informed consent was gained from
all participants. A speciﬁcally developed calendar land-
marking instrument was employed throughout the inter-
views to assist with clarifying the sequence of events and
the time periods between them.21 Interviews continued
until no new themes could be identiﬁed, indicating satur-
ation of data. All interviews were recorded and tran-
scribed verbatim. Secondary care medical records were
searched postinterview for ﬁnal diagnoses.
The Model of Pathways to Treatment19 20 was used as a
theoretical framework to guide both data collection and
analysis (ﬁgure 1) as recommended in the Aarhus state-
ment for studies of early cancer diagnosis research.22 It
deﬁnes the events and processes that can occur within
four overlapping intervals (appraisal, help-seeking, diag-
nostic and pretreatment) from the initial detection of a
Figure 1 Model of Pathways to Treatment.18
2 Hall N, et al. BMJ Open 2015;5:e008448. doi:10.1136/bmjopen-2015-008448
Open Access
bodily change to the start of treatment. It also highlights
the patient, healthcare and disease factors that can inﬂu-
ence these processes and is underpinned by established
psychological theories, including the Common Sense
Model (CSM) of Illness Self-regulation 23 and Social
Cognitive Theory.24
Data analysis
Symptom appraisal and help-seeking decisions were
explored within and across cases using an approach
based on framework analysis.25 Analysis followed ﬁve
stages: familiarisation, identiﬁcation of a thematic frame-
work, indexing, charting, mapping and interpretation.
An initial thematic framework incorporated key concepts
and themes from the interviews alongside the processes,
intervals and contributing factors from the Model of
Pathways to Treatment. All transcripts were indexed by
either NH or LB using the analytic framework and 10%
of transcripts were indexed by both researchers, with
good inter-rater reliability. The data from each interview
were summarised and charted into a coding matrix,
which was used to aid comparison within and across
cases. This allowed the range of the identiﬁed phenom-
ena to be mapped within each category and the identiﬁ-
cation of patterns and associations between themes and
across cases. In addition, a lay representative (MJ) inde-
pendently identiﬁed themes from a selection of tran-
scripts which were compared with the existing analysis
through discussion with NH and LB. Data management
was supported by NVivo9 software.
All supporting quotations are identiﬁed by sex, age
group, CRC or non-cancer (NC) diagnosis, and total
time to presentation (TTP) from ﬁrst noticing a bodily
change to their ﬁrst consultation with a healthcare
provider.
FINDINGS
Participant characteristics
Interviews were completed with 40 participants (table 1).
Eighteen participants were diagnosed with CRC and 22
with non-cancer diagnoses; 12 were unaware of their
diagnosis at the time of their interview.
Routes to help-seeking
All participants described noticing a relevant bodily
change before their initial contact with a HCP. Their
ﬁrst noticed bodily change did not always prompt a
appointment with a HCP, and referral did not always
take place after the ﬁrst presentation to a HCP (usually
their general practitioner (GP)); a third of participants
(n=13) described repeated appointments before referral.
Although many presented to their GP with a bowel-
related symptom of concern, other routes to diagnosis
were also described, such as via routine appointments
for other conditions, emergency appointments for acute
symptoms and follow-up of other investigation results.
Participants described variable patterns in the nature
of their symptoms, presentation and routes to referral
regardless of their ﬁnal diagnosis. Their symptoms
included: blood noticed on toilet paper, in the toilet
bowl or with stools; looser or more frequent stools, diar-
rhoea, constipation, or other changes to the colour, con-
sistency or shape of stools; loss of bowel control; wind
and bloating; abdominal pain, discomfort or cramps;
anaemia, fatigue, shortness of breath and weight loss.
Some reported symptoms they had not initially asso-
ciated with a ‘bowel condition’, including persistent
cough, swollen ankles, vomiting, sickness and fever.
The Model of Pathways to Treatment recognises the
dynamic, rather than linear, nature of movement
through the pathway, and this was reﬂected in the
accounts of our participants. In some cases with a sudden
onset such as an alarming rectal bleed, events and pro-
cesses had occurred simultaneously and were difﬁcult to
disentangle. Even with the aid of a calendar landmark
tool, attributing a speciﬁc time point to key events was
particularly difﬁcult for participants with vague, intermit-
tent, gradual or non-speciﬁc changes or in the presence
of existing long-standing symptoms or comorbidities.
I had the symptoms all last year but I mean I could well
have had them longer than that but they wouldn’t, you
know, it wasn’t like they were every day or all day or any-
thing and they were very mild … (Female, 65–69, CRC,
TTP: 40–52 weeks)
Regardless of their severity, intermittent symptoms
were sometimes experienced as a series of separate
appraisal episodes ‘linked’ in hindsight, rather than one
period of continual symptom monitoring:
So I think throughout, like I had periods where I wasn’t
feeling well, then I’d feel better in between…it wasn’t
one sort of constant period of not feeling well really …
(Female, 44–49, CRC, TTP: 13–26 weeks)
As a third of our participants consulted more than
once before being referred to a specialist, our ﬁndings
also reﬂect ongoing symptom appraisal and repeated
healthcare-seeking beyond the ﬁrst consultation with a
HCP.
Main themes
We identiﬁed four main interdependent and overlap-
ping themes that operated across the appraisal and help-
seeking intervals: ‘appraising and maintaining normal-
ity’; ‘matching experiences to expectations’; ‘private
nature of symptoms’, and ‘justifying healthcare use’.
These themes are presented as different lenses through
which to understand some of the ways symptom speciﬁc,
psychosocial and cultural factors interact and inﬂuence
the processes that combined to form participants’ ‘help-
seeking journeys’ (ﬁgure 2). Importantly, we did not
ﬁnd any substantive differences between people diag-
nosed with cancer and other conditions.
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Appraising and maintaining normality
Participants reﬂected on bodily changes that they subse-
quently recognised as symptoms. The detection of a
‘change’, as well as its subsequent appraisal, took place
in relation to a fairly wide spectrum of what was consid-
ered to be ‘normal’ for individuals. For example, a
change in bowel habit was compared to usual or
expected patterns in terms of timing, stool consistency
and frequency.
The ﬁrst symptoms I noticed was probably a year,
18 months ago, looser stools than would be normal but
lasting for … it wasn’t diarrhoea but it lasted for more
than the normal two or three days … (Male, 65–69, CRC,
TTP: 53+ weeks)
Table 1 Participant characteristics
Diagnosis
Total
n=40
CRC cancer
N=18
Other diagnoses*
N=22
Location of interview
East Anglia 17 8 9
North East 23 10 13
Female 18 8 10
Male 22 10 12
Age
Mean years (range) 63 (43–87) 65 (49–85) 62 (43–87)
40–59 13 4 9
60–79 23 12 11
80+ 4 2 2
Ethnicity
White British 37 17 20
Other 3 1 2
Educational qualifications†
Higher education 15 8 7
Post 16 or vocational 15 5 10
Secondary school 2 1 1
None 7 4 3
IMD quintiles
1 (least deprived) 14 6 8
2 9 5 4
3 4 1 3
4 5 2 3
5 (most deprived) 8 4 4
Referral type
2 week wait/urgent 23 14 9
Emergency 3 1 2
Routine 14 3 11
GP appointments made before referral
0 3 1 2
1 24 11 13
2 7 2 5
3 or more 6 4 2
Median weeks from 1st reported symptom to presentation (range) 12 (0–100) 13 (1–77) 11 (0–100)
Percentage of waiting >6 weeks from noticing first reported symptom
to presentation
71 81 63
Percentage of waiting >6 weeks from first noticing trigger symptom
to presentation
29 16 42
Comorbidities
IBS 2 0 2
Diabetes 3 2 1
Arthritis 11 4 7
Lung/heart disease 13 6 7
None 15 7 8
*Polyps (5), diverticulitis (5), haemorrhoids (4), IBS (4), fissure (1), angiodysplasia (1), constipation (1), anaemia (1), spirochetosis (1),
colitis (1).
†1 missing data item.
CRC, colorectal cancer; IBS, irritable bowel syndrome; IMD, Index of Multiple Deprivation; GP, general practitioner.
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These were more likely to be noticed quickly if partici-
pants had a previously regular bowel habit.
I always used to go to the loo, to pass a stool ﬁrst thing in
the morning, well about an hour after breakfast and then
I’ve noticed that actually I need to pass a stool later in
the day as well. (Female, 70–74, NC, TTP: 13–26 weeks)
Vague or non-speciﬁc changes, such as fatigue, were
particularly difﬁcult to detect and were sometimes only
recognised as ‘unusual’ with hindsight. The following
participant reported not having noticed any change at
all.
I’ve just always been like this and maybe I’ve always been
a bit anaemic so I don’t really notice the difference.
(Female, 50–54, CRC, TTP: 0–2 weeks)
The term ‘symptom’ reﬂects ‘the transition from a
bodily change to something perceived as abnormal’.20
Changes were more likely to be recognised as abnormal
when they were severe or of sudden onset, became
repeated or other changes developed, persisted beyond
an expected time, interfered with daily activities, or
became a focus of attention or concern by others.
Changes were often initially ‘normalised’ as signs of
ageing, stress or diet, or attributed to ‘stomach bugs’ or
food poisoning.
Maintaining normality was often achieved by dietary
changes, self-medication or seeking reassurance from
family or friends. Seeking healthcare was more likely
when the emotional or physical impact of symptoms
could no longer be managed or had become a threat to
normal daily life.
If you can carry on, you don’t bother to go, it’s too much
aggravation, it’s only when things start getting in the way
of what you want to do … that one bothers to think
about it as a reportable condition. (Male, 75–79, CRC,
TTP: 13–26 weeks)
You just have to carry on and soldier on for everybody
else. So I couldn’t ﬁnd the time for myself, and because
it got so bad I had to go the GP, otherwise I would have
still carried on. (Female, 45–49, NC, TTP: 13–26 weeks)
For a few participants, maintaining normality involved
a period of adaptation to severe and debilitating
Figure 2 Factors affecting symptom appraisal and help-seeking among people with colorectal cancer symptoms (GP, general
practitioner).
Hall N, et al. BMJ Open 2015;5:e008448. doi:10.1136/bmjopen-2015-008448 5
Open Access
symptoms, even faecal incontinence. For these people, a
decision to seek healthcare often required a signiﬁcant
trigger event.
Matching experience to expectations
On the basis of people’s understanding of the cause of
their symptoms, they had expectations about the likely
course and resolution of their symptoms. CRC was not
usually considered as a possible cause by those who had
presented with ‘non-bowel’ symptoms such as vomiting
or symptoms of anaemia. CRC was also not considered
by those who had attributed their bleeding to haemor-
rhoids, had been reassured about bleeding by a HCP in
the past (including recent consultations), or had
reasons to suspect other serious illness such as colitis.
The presence of blood was the symptom most likely to
prompt a consideration of cancer or the need to seek
healthcare, but this was not universal.
It was the bleeding, that was the signiﬁcant thing ‘cos I
mean that is not normal, whereas mild tummy ache or
mild bloating, you know, I think if you ask every woman
of my age they would all confess to that. (Female, 65–69,
CRC, TTP: 9–12 weeks)
Participants were more likely to consider CRC when
there was a strong family or personal history of cancer.
Expectations about the signiﬁcance of symptoms were
inﬂuenced by cultural beliefs, family and friends.
So how can I be ill if my weight doesn’t change?, because
my mam said “if you’re ill you lose weight. (Female 50–
54, NC, TTP: 40–52 weeks)
For those who had considered cancer as a potential
cause of their symptoms, negative bowel cancer screen-
ing test results, an absence of blood or pain, weight loss
or ‘not feeling ill’ were perceived as reassuring signs.
Even then I wasn’t thinking of cancer, I’d never asso-
ciated that sort of symptom (faecal incontinence) with
cancer, to me it always meant that you would have some
form of pain or you would lose weight rapidly … and feel
ill which I had none of those symptoms at all. (Male, 65–
69, CRC, TTP: 53+ weeks)
Many participants expressed concern about the possi-
bility of a cancer diagnosis, but this was usually more
prominent after their initial consultation with their GP.
Fear of cancer did not seem to be a barrier to seeking
healthcare.
People’s explanations for their symptoms were often
transient and varied over time; some were described
merely as passing or ﬂeeting thoughts. When symptoms
did not resolve as expected, alternative causes were con-
sidered. Knowledge and awareness of cancer signs,
although important, were not sufﬁcient, nor always
necessary, for a decision to seek healthcare promptly.
A decision to seek healthcare was triggered when symp-
toms no longer matched what was expected in terms of
frequency, duration, severity or impact on daily life or
when alternative explanations could not be found.
The private nature of symptoms
Since colorectal symptoms are mostly experienced pri-
vately, many participants felt that opportunities for com-
paring symptoms with others were more limited than
with other more ‘visible’ symptoms such as a persistent
cough; this could make their signiﬁcance harder for
people to assess. We also found that sociocultural norms
about the private nature of colorectal symptoms could
reduce opportunities for detection and inﬂuence
symptom appraisal.
Me personally, the way I was brought up, one, you don’t
talk about downstairs, and two, you don’t look at down-
stairs. So, when people ask me questions like “Is it in the
stool?” or anything like that, I tend not to look, I do now
but I didn’t then. (Female, 50–54, NC, TTP: 40–
52 weeks)
Nonetheless, many people reported speaking to part-
ners, family, friends and work colleagues about their
symptoms. When symptoms usually contained within the
home could no longer be controlled or ‘hidden’, the
embarrassment and impact on daily life could act as a
trigger for seeking healthcare.
I’ve been having that wind problem. (Laughs) … It’s hor-
rible, really embarrassing. And if I should be out and I
get this sort of urge to go to the toilet, I have to go other-
wise I’ve pooed myself … Very embarrassing. (Female,
70–74 NC, TTP: 13–26 weeks)
Many participants had been aware that an appoint-
ment with their doctor about their colorectal symptoms
might involve a rectal examination, and some were
aware of the possibility of further invasive investigations
such as colonoscopy. Few felt this had affected their
decision to seek healthcare. Concern about being per-
ceived to be wasting the doctor’s time was more likely to
be reported. Nevertheless, when embarrassment or
other concerns about invasive investigations were
present, these could present a signiﬁcant barrier to
consultation.
I did think about it a few times before I actually went
(sighs) but I don’t know why, nothing to do with thinking
about cancer, it was just the embarrassment of knowing
that I might have to have somebody’s ﬁnger pushed up
your bum for an examination … that was probably the
thing that put me off going more than anything in the
ﬁrst instance was the embarrassment of that sort of thing
… I don’t suppose anybody likes, whether it’s a doctor or
not, playing around what you consider as your private
parts and that, it’s not the most pleasant of experiences.
(Male, 65–69, CRC, TTP: 53+ weeks)
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Potential embarrassment about an intrusive test such
as colonoscopy could be outweighed by the concern
caused by the symptoms and the need for reassurance.
Some suggested that embarrassment around invasive
procedures reduced with age.
I mean, I’m at an age now where it doesn’t matter to me
who I see, I don’t mind people ﬁddling around with me
whatever gender they are … You lose all this, kind of,
this, sort of dignity and stuff as the years go by. (Male,
80–84, NC, TTP: 5–8 weeks).
Justifying the use of healthcare
Participants’ reactions to symptoms depended on
symptom attributions, as well as on culturally deﬁned
and implicit beliefs about the appropriate use of health-
care. These beliefs had the most impact during the deci-
sion to seek healthcare, yet also inﬂuenced continued
symptom appraisal and self-management. Concerns
about being perceived to ‘waste the doctor’s time’ and
using publicly funded healthcare resources inconsider-
ately were commonly reported. Waiting for a symptom
to recur, persist or worsen allowed a ‘justiﬁcation’ of the
use of healthcare resources. Participants rarely talked
about the time taken to present to a HCP in terms of
intentional delay and were more likely to report that
they had sought care as soon as they realised this was
necessary or they felt justiﬁed in doing so.
I went online to book an appointment and the ﬁrst one
that came up was three weeks ahead, and I thought that’s
ﬁne by me … if they (symptoms) haven’t gone away then
I’ll feel justiﬁed in bothering her really. (Female, 65–69,
CRC, TTP: 5–8 weeks)
For those with a cancer concern, the importance of
‘catching it early’ and having a good relationship with
the HCP were used to legitimise healthcare-seeking.
Bleeding or pain were seen to be more legitimate
reasons for consulting than non-speciﬁc symptoms
regardless of whether they were associated with a cancer
concern or not. A recent negative bowel screening test
meant that consulting was seen as less appropriate by
some participants.
It wasn’t sufﬁcient really to go to the doctor, I didn’t
think so because I’d already had two of the bowel cancer
tests that come through the post. (Male 65–69, CRC,
TTP: 53+ weeks)
A national bowel cancer awareness campaign took
part during our study period ( January–March 2012).
Advertisements encouraged people with blood in their
stools or looser stools for 3 weeks to present to a GP and
to not be embarrassed about their symptoms. Not every-
one who had seen the campaign associated the message
with their symptoms, although it helped to trigger and
legitimise repeated help-seeking for one woman who
presented to her GP three times before she was
referred.
People said if you have it for three weeks, any sign of
blood, get yourself to doctor, doesn’t matter how embar-
rassed, just say it to your doctor. This is what I did, I fol-
lowed the campaign … and I went back straightaway
because I know it’s not right. (Female, 50–54, CRC, TTP:
13–26 weeks)
Not all the participants believed that their symptoms
warranted a speciﬁc appointment with their GP and
some participants mentioned their colorectal symptoms
only during follow-up or routine appointments.
I was talking to him [GP] and then I thought, “Yeah, I’ll
tell him, I’ll ask him about it … Well yeah. I thought,
“It’s silly not to, I’m here.” You know, it’s more practical
to ask him about it, so I did. (Female, 60–64, CRC, TTP:
9–12 weeks)
Although for some participants talking to family and
friends had an important inﬂuence on their decision-
making, this was not the case for everyone.
Encouragement from signiﬁcant others could act as
both a prompt and a means of legitimising
healthcare-seeking.
My youngest daughter said you can’t, she’s a bit on the
bossy side, “Don’t leave it Mam, go.” And so I probably
would have left it a bit longer if she hadn’t have said.
(Female, 65–69, NC, TTP: 0–2 week)
Reassurance could have the opposite effect and
resulted in delayed healthcare-seeking for the following
participant.
I choose to see my doctor but when I talk to a few
friends, they say “oh we all have constipation here” … so
I just ignore it. (Female, 50–54, CRC, TTP: 13–26 weeks)
For those who had presented to their GP more than
once, advice from the doctor about appropriate repeat
visits, when provided, had been an important facilitator
for timely repeat consultations, inﬂuencing symptom
monitoring and legitimising the continued use of
services.
DISCUSSION
Principal findings
This study has conﬁrmed that recognising the signiﬁ-
cance of common symptoms associated with CRC is far
from straightforward, and is often a challenge for
patients prior to seeking healthcare.8 Our ﬁndings high-
light a range of interacting and often competing biopsy-
chosocial, contextual and cultural inﬂuences on the way
in which people recognise, interpret and act on their
symptoms of CRC. Importantly, we did not ﬁnd any sub-
stantive difference between people diagnosed with
cancer and other conditions. Bodily changes are
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appraised within the context of usual bowel patterns,
comorbidities and life events, and people attempt to
maintain normality through ﬁnding benign explanations
for their symptoms. Decisions to seek help often occur
only when their expectations about the course of symp-
toms are not met. Our most novel ﬁnding relates to the
private nature of CRC symptoms which may affect their
identiﬁcation as well as discussion with others including
HCPs; once it becomes impossible to conceal their
private nature, this may also prompt help-seeking.
Within the context of the publicly funded National
Health Service, people needed to legitimise appropriate
use of healthcare services and avoid being seen to be
wasting doctors’ time.
Strengths and weaknesses of this study
This qualitative study was embedded in a large prospect-
ive cohort study, which allowed us to purposively sample
from a wide range of perspectives and sociodemo-
graphic backgrounds. This is one of the ﬁrst such
studies to include a reasonably large sample of patients
with similar symptoms, not all of whom had a ﬁnal diag-
nosis of CRC. Importantly, participants were recruited
either before diagnosis or shortly afterwards, reducing
potential recall bias. Both data collection and analysis
were underpinned by the Model of Pathways to
Treatment which has a strong psychological theoretical
basis.20 We also used a calendar landmark instrument
which is designed to improve the chronology of the
symptom pathways reported by participants.21 Analysis
was performed by a group of experienced qualitative
researchers from different disciplinary backgrounds; in
addition, we included a patient representative to provide
a unique perspective to the analysis and interpretation.
There are some limitations to our study. Despite our
efforts to reduce recall bias, there will probably be some
post hoc rationalisation of patients’ experiences, particu-
larly for those who knew their cancer diagnosis at the
time of the interview. Although we were able to include
three participants from ethnic minority groups, this was
not enough to make conclusions regarding speciﬁc cul-
tural inﬂuences.
Comparison with existing literature
Previous research in a range of cancers has identiﬁed
normalisation as a way of coping with, and minimising,
symptoms.26 Our ﬁndings also reﬂect the social and cul-
tural context in which these processes occur, mirroring
research based on Alonzo’s concept of containment.27
Our participants’ accounts demonstrate that although
knowledge and awareness of the signs of CRC can have
an important inﬂuence, they are not always necessary,
nor sufﬁcient, for timely healthcare-seeking. Indeed, a
mismatch between expectations and experienced symp-
toms can inﬂuence beliefs about the perceived serious-
ness and the need to seek healthcare. Similar ﬁndings
came from a recent Danish study where most patients
recently diagnosed with CRC had not attributed their
initial symptoms to cancer, and only rectal bleeding was
likely to make people consider cancer.28 Our study also
conﬁrmed previous research in pancreatic cancer that
intermittent symptoms were acted on only when a
pattern was identiﬁed, there was a change in their fre-
quency or nature, or they became associated with add-
itional symptoms.29 Many of the heuristics from
established psychological research known to inﬂuence
the interpretation of symptoms were apparent in our
data and are reﬂected across our second theme ‘match-
ing experience with expectations’.20 For example, a lack
of bleeding, pain or weight loss, intermittent symptoms
and not feeling ‘ill’ conﬁrmed ‘non-worrying’
attributions.
The inﬂuence of the private nature of colorectal symp-
toms provides a novel insight into possible reasons for
later help-seeking. This impacted on whether people
observed subtle changes in their stools, as well as on
whether these were discussed with close others.
Interestingly, once symptoms could no long be kept
private (eg, wind or diarrhoea), this could also act as a
prompt for help-seeking. These ﬁndings add to previous
studies relating to the effect of embarrassment on help-
seeking,10 16 30 although interestingly embarrassment of
physical examination or investigation was not a common
barrier in this study. For the few participants in whom it
was present, however, it could present a major barrier to
prompt help-seeking. Our ﬁnal theme identiﬁed cultur-
ally deﬁned and implicit beliefs about the appropriate
use of healthcare. Concern about ‘wasting the doctor’s
time’ is more common in the UK than in other compar-
able countries,31 and may be an important barrier to
prompt help-seeking in publicly funded healthcare
systems. The tension between wasting the doctor’s time
and raising a concern about health has been discussed
previously,32 and a study of patients with lung cancer
described how thresholds for healthcare-seeking
reﬂected ‘shared societal norms of when professional
care should be sought’.33
Implications for practice and policy
Our ﬁndings have important implications for public
health and primary care strategies to optimise early
symptomatic diagnosis of CRC. The most novel ﬁnding
relates to how the private nature of bowel symptoms can
contribute to longer symptom appraisal and later pres-
entation to healthcare. Once they are no longer
‘private’, they can also trigger help-seeking. Awareness
campaigns should continue to aim to reduce the stigma
of looking for changes in bowel movements and discuss-
ing bowel symptoms with family friends and health pro-
fessionals.34 They also need to consider the mismatch
between the expected and actual experience of cancer
symptoms, particularly in relation to intermittent symp-
toms or clusters of non-speciﬁc, lower risk symptoms.4
However, awareness campaigns can exacerbate the
tension between prompt help-seeking for common
symptoms and concerns about wasting the doctor’s time.
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Altering perceptions about the appropriate use of
health services could have a beneﬁcial effect on TTP,
particularly in the UK and other countries with publicly
funded healthcare.
In conclusion, the ﬁndings from this study provide
fresh insights into how people appraise and act on their
colorectal symptoms. We did not ﬁnd any differences
between people who progressed to a malignant or
benign diagnosis. The ﬁndings could underpin novel
approaches to community awareness campaigns.
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